RI-STAD 2

• Description:

  AKAP disruptor. Selectively binds PKA-RI with high affinity (KD values are 6.2 and 12.1 nM for the RIα and β subunits, respectively) and blocks its interaction with AKAP. Inhibits type I PKA-mediated phosphorylation in live cells. Cell permeable.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  2401.75

• Molecular Formula:

  C109H181N25O35

• Notes:

  Research use only, not for human use.

• Receptor:

  ——